Clinical Trials

Only one dose of the monoclonal antibody (mAb) CIS43LS gave out high levels of protection against Malaria in challenge study as per new research. While the previous research that were conducted put out the fact that the monoclonal antibodies...

Conducting a decentralized clinical trial (DCT) can sometimes feel like conducting an orchestra. Tracking and connecting the moving parts, siloed service providers, and disparate technology systems can all serve to detract from the model’s stated aim of streamlining clinical...

The UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 has been published by Cell and Gene Therapy (CGT). T cells were said to be the most commonly looked-at cell type in its data. As per the research, this...

The Clinical Trial Information System went live on January 31, 2022, which began the one-year transition period for all clinical trial sponsors. Clinical trial sponsors are still free to decide whether to submit an initial clinical study application via...

CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes announced a partnership between its ATCOR subsidiary and Invaryant, a data-driven health technology company that empowers individuals with precision AI to...

Data shown at the 64th American Society of Haematology (ASH) conference in New Orleans demonstrates that elranatamab is effective and has a controllable effectiveness and safety in patients with relapsed or refractory multiple myeloma (RRMM). Multiple myeloma (MM) is a...

BioNTech SE announced the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate from the Company’s BNT165 program, to develop a multi-antigen malaria vaccine candidate. BioNTech will initially evaluate a set of mRNA-encoded antigens of the...